Search

everythinglearnresearchcommunity

for

Search:↓

Optimizing the structure of a specific compound greatly improved its effectiveness and precision for treating diabetic complications.

Itraconazole-loaded nanoparticles are more effective and less toxic for treating fungal infections than conventional oral itraconazole.

Olorofim effectively treats fungal skin infections.

Isoalantolactone promotes hair growth by activating specific cell pathways.

Adapalene, Diosmin, and Azelastine could be repurposed to treat onchocerciasis.

Lysocellin helps stop cell damage from etoposide and may prevent hair loss.

Epristeride's metabolism in zebrafish helps improve doping detection methods.

New itaconate prodrugs improve its absorption and effectiveness for treating inflammation.

Inositol was more effective than Metformin in treating symptoms of PCOS in women.

Epristeride's metabolism involves key metabolites and proteins, affecting its use in doping tests.

Adapalene, Diosmin, and Azelastine may effectively treat onchocerciasis.

Adapalene, Diosmin, and Azelastine may effectively treat onchocerciasis.

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

A new compound from a sponge strongly inhibits an enzyme linked to male-pattern hair loss without being toxic at low levels.

Some new isatin compounds could be strong cancer-fighting drugs because they fit well in cancer-related proteins and have good drug-like properties.

Compounds 15, 20, and 25 are strong inhibitors of human steroid 5α-reductase type 2.

Myo-inositol and D-chiro-inositol, especially in a 40:1 ratio, effectively treat PCOS by improving insulin sensitivity and ovulation.

Myo-inositol-based treatments greatly improve pregnancy chances for women with PCOS.

The combined therapy improved fertility in women with PCOS, especially in certain types.

Myo-inositol may be more effective than metformin for inducing ovulation in women with PCOS.

Inhibiting plant sterols reduces grapevine pathogen reproduction.

New steroidal compounds moderately block an enzyme related to testosterone conversion, less effectively than finasteride.

The document concluded that certain compounds might strongly bind to and potentially inhibit a key SARS-CoV-2 protein, but further testing is needed.

New pregnane derivatives were more effective than finasteride at inhibiting a key enzyme for male pattern baldness.

Convulsofin effectively treats primary epilepsy but has some side effects.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

Effective, well-tolerated, and affordable treatments are needed for recurrent ischemic priapism.

Cepharanthine and Trifluoperazine are effective against SARS-CoV-2.

Stiripentol shows promise as a potential treatment for androgen-related diseases but needs more testing.